ClinicalTrials.gg
Status unknownNCT03596853Updated May 1, 2019

Progressive Mobilization With Dose Control and Training Load in in Critically Ill Patients

An interventional study of Progressive mobilization and Usual Care in Critically Ill, sponsored by Federal University of Bahia. Status unknown at 1 site in Brazil. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2019-05-01.

Sponsored by Federal University of Bahia · Not applicable, Interventional, and Treatment

The sponsor has not verified this record recently (last verified Apr 2019), so the status shown — last known as Not yet recruiting — may be out of date.
Phase
Not applicable
Study type
Interventional
Enrollment
104
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

Immobilization and bed rest of patients in intensive care units (ICU) increases their risk for muscle dysfunction and prolonged mechanical ventilation, leading to physical deconditioning and loss of functionality. Active mobilization is a therapeutic strategy that typically involves exercises in which the patient uses his or her own strength and muscular control, is a feasible, safe, and low-cost intervention to improve muscle dysfunction and disability in patients at the ICU. Despite scientific advances, the current description and prescriptions of exercises at the ICU remain incomplete with respect to the control and the description of the variables of training load (volume and intensity), programming, and progression.

Read the detailed description

This prospective double-blind (patient and evaluator). This study will be conducted in accordance with Consolidated Standards of Reporting Trials recommendations. The trial will be performed at the University Hospital Professor Edgard Santos in Salvador, Bahia, Brazil. This study was approved by the institutional hospital ethics committee (approval reference number 2.371.933). Before enrollment, written informed consent will be obtained from participants or their legal guardians.

02

Conditions studied

  • Critically Ill

Browse trials for

03

In context

Critical Illness

1,931 studies on the registry are indexed under Critical Illness; 469 are open to participants now.

This study's planned enrollment of 104 is above the median of 90 across 1,007 interventional studies indexed under Critical Illness.

Browse Critical Illness studies →

Lead sponsor

Federal University of Bahia is the lead sponsor of 40 studies on the registry; 4 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Being able to roll in the bed and bridge.
  • Barthel score of at least 70 weeks before admission to the ICU
  • Ability to interact with the researcher

Exclusion criteria

Exclusion Criteria:

  • Mortality rate in excess of 50% according to Acute Physiology and Chronic Health Disease Classification System II (APACHEII)
  • Present intracranial pressure increase
  • Cardiorespiratory arrest,
  • Has unstable fractures that hamper progression in levels of mobilization,
  • Severe lower limb injury or amputation
  • Neuromuscular disease
  • Underwent radiotherapy and / or chemotherapy in the last 6 months.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
104 participants (estimated)

Study arms

  • Experimental
    Experimental: Mobilization

    These patients will receive standard rehabilitation delivered by non-study physiotherapist. In addition, the patients will undergo a protocol of progressive mobilization with individualized dose control and training load stratified according to functional levels and performance.

    Other: Progressive mobilization

  • Sham comparator
    Control: Usual care

    These patients will receive standard rehabilitation delivered by non-study physiotherapist.

    Other: Usual Care

Interventions

  • OtherProgressive mobilization

    Will be applied once a day, 5x/ week, performed into 4 levels: N1 (bridge and rolling for both sides); N2 (transfer training from lying down to sitting on both sides); N3 (sit and stand up from a chair); N4 (running training). According to their functional level, patients will perform, once a day, 8 sets of each movement, alternating 20 seconds of execution with 10 seconds of rest. Patients will be stimulated constantly to perform the movements with the highest possible speed. If the patient performs adequately within of your level functional level, can will progress in level, if can not progress, there will be an increase in training volume within the level itself. Adequate performance within the functional level means that the patient is able to complete more than eight sets of exercise and does not present increased sensation of pain, present sensation of perceived exertion within the safety limit of the protocol (Borg ≤ 6).

  • OtherUsual Care

    This group will receive standard usual, which will be monitored, but not protocolised.

06

What researchers measure

Primary outcomes

  1. Length of ICU stay in days

    Time in days, from baseline to discharge from ICU

    Time frame: at 28 days or discharge from ICU whichever occurs earlier

Secondary outcomes

  1. Muscle mass

    Ultrasound measurement (quadriceps, biceps brachii, and diaphragm - cross-sectional area on B-mode ultrasound

    Time frame: Change from baseline at 28th day

  2. Change in muscle strength

    Muscle Strength measured by hand held dynamometer

    Time frame: Baseline and after 3 and at 7 day intervals up to 28th day or discharge from ICU

  3. Physical activity: total activity

    accelerometry measurement of the total activity

    Time frame: At 28 days or discharge from hospital

  4. Activity and participation

    Measurement characteristics of World Health Organisation Disability Assessment Schedule II

    Time frame: Change from baseline up to 1 year post discharge

  5. Mortality

    Mortality

    Time frame: At 28 days or discharge from hospital and at 12 months

  6. Functional Status

    Functional Status Measured Using Functional Status Score for the Intensive Care Unit (involves five functional tasks (rolling, supine to sit transfer, sit to stand transfer, sitting on the edge of bed and walking). Each task is evaluated using an 8-point ordinal scale ranging from 0 (not able to perform at all) to 7 (complete independence)

    Time frame: Change from baseline up to 28th day or discharge from hospital

  7. Surgical Optimal Mobilisation Score (SOMS) level

    Surgical Optimal Mobilisation Score (SOMS) level algorithm for goal-directed mobility ranges from '0-No mobility' to '4-Ambulation'. The intermediate steps are '1-Passive Range of Motion,' '2-Sitting,' and '3-Standing.'

    Time frame: Change from baseline up to 28th day or discharge from hospital

  8. Mobility

    Timed up-and-go score

    Time frame: Change from baseline up to 28th day or discharge from hospital

  9. Health-Related Quality of Life: SF-36

    Health-Related Quality of Life will be measured by a questionnaire 36-item Short Form Health Survey. The SF-36 is a widely used generic instrument for evaluating HRQoL, consisting of eight subscales evaluating specific health status domains and two summary scales, a Physical Component Summary and a Mental Component Summary. Scores on the SF-36 range from 0 to 100, with higher scores indicating better health status.

    Time frame: At 28 days or discharge from hospital and at 12 months

  10. Days with mechanical ventilation

    Number of uninterrupted days in use of mechanical ventilation

    Time frame: From 3 to 28 days

  11. Length of hospital stay in days

    Time in days, from baseline to discharge from hospital

    Time frame: Up to 1 month post hospital discharge

  12. Muscle thickness

    Ultrasound measurement (quadriceps, biceps brachii, and diaphragm on B-mode ultrasound measured in mm

    Time frame: Change from baseline at 28th day

07

Study locations

1 site
  • Mansueto Gomes Neto
    Salvador, Estado de Bahia 41950350, Brazil
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 1, 2019, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03596853
Lead sponsor
Federal University of Bahia
Responsible party
Mansueto Gomes Neto (Principal Investigator, Federal University of Bahia) — Principal investigator
First posted
Jul 24, 2018
Start date
Jun 1, 2019 (estimated)
Primary completion
Jul 31, 2020 (estimated)
Completion
Jul 31, 2022 (estimated)
Last update
May 1, 2019

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Apr 2019. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion